These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5612996)

  • 21. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects of phenothiazines.
    Br Med J; 1972 Feb; 1(5797):441. PubMed ID: 5058169
    [No Abstract]   [Full Text] [Related]  

  • 24. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term therapy with depot-fluphenazine Dapotum in schizophrenia].
    Moldenhauer B
    Med Welt; 1966 Jul; 27():1477-81. PubMed ID: 5985539
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment with depot neuroleptic drugs in psychiatry].
    Heinrich K
    Evol Psychiatr (Paris); 1970; 35(14):953-5. PubMed ID: 5508726
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of schizophrenia with fluphenazine].
    Kerzeniewski L; Puzynski S
    Acta Neurol Psychiatr Belg; 1966 Mar; 66(3):213-7. PubMed ID: 4958235
    [No Abstract]   [Full Text] [Related]  

  • 28. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
    Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
    J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fluphenazine in the treatment of schizophrenia].
    Fouks ; Périvier ; Lerno ; Gilbert
    Ann Med Psychol (Paris); 1966 May; 124(5):698-702. PubMed ID: 5941461
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
    Deverteuil R; Lehmann HE; Ban TA; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):219-22. PubMed ID: 5550418
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute paranoid schizophrenia. (Treatment with chlorpromazine, trifluoperazine and placebo).
    Reardon JD; Abrams S
    Dis Nerv Syst; 1966 Apr; 27(4):265-70. PubMed ID: 5936140
    [No Abstract]   [Full Text] [Related]  

  • 33. A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W; Boisvert D; Bradwejn J
    Psychopharmacol Bull; 1984; 20(1):108-9. PubMed ID: 6371871
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 35. Flupheazine enenthate and schizophrenia.
    Valentine M; Trueman H
    Br Med J; 1968 Nov; 4(5626):328. PubMed ID: 5687977
    [No Abstract]   [Full Text] [Related]  

  • 36. Sleep disturbance associated with fluphenazine HCl: a case report.
    Kramer BA
    Am J Psychiatry; 1979 Jul; 136(7):977-8. PubMed ID: 453364
    [No Abstract]   [Full Text] [Related]  

  • 37. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of haloperidol in residual schizophrenia and in the paranoid states].
    Jeri FR
    Rev Neuropsiquiatr; 1970 Jun; 33(2):114-22. PubMed ID: 5509272
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of nicotinic acid in the treatment of chronic schizophrenia].
    Maslowski J
    Psychiatr Pol; 1967; 1(3):307-11. PubMed ID: 5593258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.